Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
3 RGN-259 Phase 3 Trial in Neurotrophic Keratopathy Sosne et al., International Journal of Molecular Sciences (2022) This Phase 3 randomized, placebo-controlled, double-masked clinical trial evaluated topical 0.1% RGN-259 (full-length recombinant T4 ophthalmic solution) in patients with neurotrophic keratopathy
In order to ensure the highest quality of the product, laboratory tests for concentration and purity, which can be found in the Studies tab, are carried out for each batch of the product
Also see our BPC-157 + TB-500 blend research guide for related stacking protocols
It is a peptide that is made from human gastric juice
By boosting B12 levels, you can support your bodys ability to fight off infections and illnesses, making you feel more resilient and energetic
Early data is interesting, but rigorous science and patient safety must come first
US$ 22.29
US$ 20.33
US$ 29.23
US$ 23.82
US$ 22.43
US$ 23.92
